Herbalife's Stock Soars 79%: Is the Rally Sustainable After Strong Q4?

Herbalife Ltd. (NYSE: HLF) is riding a wave of investor optimism, with its stock price climbing to $18.10—a staggering 79.4% gain over the past six months. The jump was fueled by better-than-expected fourth-quarter earnings, prompting many to reconsider the nutritional supplement company's prospects. Yet beneath the headline numbers, a closer look reveals persistent challenges that could temper the enthusiasm.

While revenue projections from Wall Street analysts point to a modest 4.3% growth over the next year—driven by newer product lines—this remains below the sector average. More concerning is the 3.9% decline in average quarterly sales volume over the last two years. For a consumer staples business, volume is critical; when branded products become too expensive, customers often switch to cheaper alternatives.

Profitability tells a similar story. Over the past three years, Herbalife's earnings per share have fallen by 14.4% annually, a steeper drop than its revenue decline. This suggests the company has struggled to adjust its cost structure amid softening demand. "Herbalife is at a crossroads," says market analyst Rebecca Shaw of FinSight Advisors. "The recent stock performance reflects short-term relief, not a fundamental turnaround. Until volume trends reverse, the rally looks fragile."

At a forward P/E of 7.8×, Herbalife's valuation appears reasonable, but it may already price in limited near-term upside. For investors seeking growth, more dynamic plays in the health and wellness space—or even in adjacent sectors like digital advertising—could offer clearer pathways.

Investor Reactions:

• Michael Torres, Portfolio Manager at Grove Capital: "I'm cautiously optimistic. Herbalife has navigated regulatory headwinds before, and their new product pipeline shows promise. At this multiple, there's room for error."
• Sarah Chen, Retail Investor & Long-time Shareholder: "This feels like a dead-cat bounce. The volume drop is a red flag—you can't cut your way to growth forever. I'm trimming my position."
• David Park, Independent Financial Advisor: "For income-focused clients, the dividend yield is still attractive. But growth investors should look elsewhere until operational metrics improve."
• Lisa Rodriguez, Consumer Goods Analyst at The Street: "It's baffling how quickly markets forget. Herbalife's model remains controversial, and volume erosion suggests core customers are slipping away. This rally is built on sand."

WHILE YOU’RE HERE: Top 9 Market-Beating Stocks. The best stocks don't just beat the market once. They do it again. And again. Robust revenue growth, rising free cash flow, returns on capital that leave their competition in the dust. The market has already rewarded these businesses.

But our AI platform says the party isn't over. Find out which 9 stocks made the cut this week — FREE. Get Our Top 9 Market-Beating Stocks for Free HERE.

Stocks that have made our list include now familiar names such as Nvidia (+1,326% between June 2020 and June 2025) as well as under-the-radar businesses like the once-micro-cap company Tecnoglass (+1,754% five-year return). Find your next big winner with StockStory today.